gms | German Medical Science

G-I-N Conference 2012

Guidelines International Network

22.08 - 25.08.2012, Berlin

Price-tag of a European ESHRE guideline: price versus quality and speed of development

Meeting Abstract

Suche in Medline nach

  • N. Vermeulen - European Society of Human Reproduction and Embryology, Grimbergen, Belgium
  • W.L.D.M. Nelen - European Society of Human Reproduction and Embryology, Grimbergen, Belgium; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Guidelines International Network. G-I-N Conference 2012. Berlin, 22.-25.08.2012. Düsseldorf: German Medical Science GMS Publishing House; 2012. DocP054

doi: 10.3205/12gin166, urn:nbn:de:0183-12gin1665

Veröffentlicht: 10. Juli 2012

© 2012 Vermeulen et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Background: We recently started developing evidence-based guidelines within the field of human reproduction. The process, as described in a manual, is executed by 10–15 expert-volunteers, supported by a research specialist for literature evaluations.

Objectives: After one year, we evaluated the price-tag of a guideline and how costs are related to quality and speed of development.

Methods: We questioned our first guideline group on the current development strategy and on methods for increasing speed and quality and/or decreasing costs.

Results: Up to writing recommendations, the first guideline has cost €55600, mainly actual costs from meetings and wages. The total price for this guideline is estimated at €70000. On the questionnaire, all group members reported that the 3 past meetings were necessary and useful, 75% found the number of meetings sufficient and more than 80% found that the meetings were organized at good time points in the process. 75% of the members agreed a 1-week meeting for evidence evaluation, and writing recommendations would speed up the process, 37,5% believes it would decrease quality. Only 12,5% of the members agreed a second research specialist would speed up the process and improve the quality. The results for 2 additional guideline groups are being collected.

Discussion: Costs for guideline development can be kept relatively low by having only 1 research specialist and limited meetings, making guideline development feasible for international organizations. To speed up the guideline development, a 1-week meeting to perform the entire evidence selection process could be considered.